Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4HCM3
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 3 |
GO:0032259 | methylation | 2 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0008168 | methyltransferase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.390 |
CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.271 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.467 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.468 |
DOC_CYCLIN_RxL_1 | 24 | 33 | PF00134 | 0.264 |
DOC_MAPK_MEF2A_6 | 236 | 244 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 35 | 43 | PF00069 | 0.455 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.392 |
DOC_WW_Pin1_4 | 132 | 137 | PF00397 | 0.359 |
LIG_Actin_WH2_2 | 180 | 197 | PF00022 | 0.300 |
LIG_Actin_WH2_2 | 223 | 238 | PF00022 | 0.258 |
LIG_AP2alpha_2 | 248 | 250 | PF02296 | 0.412 |
LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.266 |
LIG_BRCT_BRCA1_1 | 99 | 103 | PF00533 | 0.359 |
LIG_Clathr_ClatBox_1 | 244 | 248 | PF01394 | 0.260 |
LIG_Clathr_ClatBox_1 | 29 | 33 | PF01394 | 0.392 |
LIG_CtBP_PxDLS_1 | 136 | 140 | PF00389 | 0.341 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.184 |
LIG_FHA_2 | 219 | 225 | PF00498 | 0.270 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.383 |
LIG_LIR_Gen_1 | 17 | 26 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 177 | 187 | PF02991 | 0.300 |
LIG_LIR_Gen_1 | 237 | 247 | PF02991 | 0.235 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.238 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 237 | 242 | PF02991 | 0.232 |
LIG_LIR_Nem_3 | 248 | 253 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 33 | 39 | PF02991 | 0.233 |
LIG_NRBOX | 240 | 246 | PF00104 | 0.253 |
LIG_NRBOX | 71 | 77 | PF00104 | 0.420 |
LIG_PCNA_yPIPBox_3 | 67 | 76 | PF02747 | 0.301 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.224 |
LIG_SH2_GRB2like | 20 | 23 | PF00017 | 0.407 |
LIG_SH2_NCK_1 | 20 | 24 | PF00017 | 0.411 |
LIG_SH2_PTP2 | 84 | 87 | PF00017 | 0.359 |
LIG_SH2_SRC | 20 | 23 | PF00017 | 0.407 |
LIG_SH2_STAP1 | 16 | 20 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.300 |
LIG_SH3_3 | 243 | 249 | PF00018 | 0.422 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.392 |
LIG_SUMO_SIM_anti_2 | 138 | 145 | PF11976 | 0.341 |
LIG_SUMO_SIM_anti_2 | 155 | 160 | PF11976 | 0.221 |
LIG_SUMO_SIM_anti_2 | 243 | 248 | PF11976 | 0.261 |
LIG_SUMO_SIM_anti_2 | 71 | 80 | PF11976 | 0.445 |
LIG_SUMO_SIM_par_1 | 243 | 248 | PF11976 | 0.261 |
LIG_SUMO_SIM_par_1 | 28 | 33 | PF11976 | 0.332 |
LIG_WRC_WIRS_1 | 176 | 181 | PF05994 | 0.359 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.300 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.239 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.348 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.196 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.554 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.448 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.423 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.477 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.319 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.497 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.341 |
MOD_NEK2_1 | 188 | 193 | PF00069 | 0.318 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.341 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.439 |
MOD_Plk_2-3 | 104 | 110 | PF00069 | 0.239 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.297 |
MOD_ProDKin_1 | 132 | 138 | PF00069 | 0.359 |
MOD_SUMO_for_1 | 170 | 173 | PF00179 | 0.341 |
MOD_SUMO_rev_2 | 98 | 108 | PF00179 | 0.295 |
TRG_DiLeu_BaEn_1 | 237 | 242 | PF01217 | 0.231 |
TRG_DiLeu_BaEn_1 | 68 | 73 | PF01217 | 0.593 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.425 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.225 |
TRG_ER_diArg_1 | 54 | 57 | PF00400 | 0.402 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I266 | Leptomonas seymouri | 53% | 100% |
A0A0S4J1S6 | Bodo saltans | 36% | 84% |
A0A1X0NX63 | Trypanosomatidae | 42% | 100% |
A0A3S7WXK7 | Leishmania donovani | 79% | 100% |
A4I047 | Leishmania infantum | 79% | 100% |
A4IGU3 | Xenopus tropicalis | 26% | 100% |
E9AW10 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4QBG6 | Leishmania major | 77% | 100% |